RU2018140501A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018140501A3 RU2018140501A3 RU2018140501A RU2018140501A RU2018140501A3 RU 2018140501 A3 RU2018140501 A3 RU 2018140501A3 RU 2018140501 A RU2018140501 A RU 2018140501A RU 2018140501 A RU2018140501 A RU 2018140501A RU 2018140501 A3 RU2018140501 A3 RU 2018140501A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662324600P | 2016-04-19 | 2016-04-19 | |
| US62/324,600 | 2016-04-19 | ||
| PCT/CA2017/050475 WO2017181277A1 (en) | 2016-04-19 | 2017-04-18 | Pegylated bioactive peptides and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018140501A RU2018140501A (ru) | 2020-05-19 |
| RU2018140501A3 true RU2018140501A3 (cg-RX-API-DMAC10.html) | 2020-09-08 |
| RU2748576C2 RU2748576C2 (ru) | 2021-05-27 |
Family
ID=60039750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018140501A RU2748576C2 (ru) | 2016-04-19 | 2017-04-18 | Пэгилированные биологически активные пептиды и их применение |
Country Status (18)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020205498A1 (en) | 2019-03-29 | 2020-10-08 | The General Hospital Corporation | Ghrh or analogues thereof for use in treatment of hepatic disease |
| CN116194344B (zh) | 2020-10-09 | 2026-06-30 | 奥托立夫开发公司 | 安全气囊装置 |
| CN114195881B (zh) * | 2021-12-16 | 2022-09-16 | 浙江湃肽生物股份有限公司 | 一种制备醋酸舍莫瑞林的方法 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4659693A (en) | 1984-04-30 | 1987-04-21 | Syntex (U.S.A.) Inc. | N,N'-dialkyl substituted guanidino amino acyl residue substituted GRF-analog peptides |
| US4622312A (en) | 1984-09-24 | 1986-11-11 | Hoffmann-La Roche Inc. | Growth hormone releasing factor analogs |
| US4689318A (en) | 1985-08-29 | 1987-08-25 | The Salk Institute For Biological Studies | GRF analogs |
| US4914189A (en) | 1987-02-05 | 1990-04-03 | The Adminstrators Of The Tulane Educational Fund | Synthetic GHRH analogs |
| DE3726324A1 (de) | 1987-08-07 | 1989-02-16 | Hoechst Ag | Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute |
| US5023322A (en) | 1988-08-31 | 1991-06-11 | Mta Kutatas-Es Szervezetelemzo Intezete | Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof |
| US5084442A (en) | 1988-09-06 | 1992-01-28 | Hoffmann-La Roche Inc. | Cyclic growth hormone releasing factor analogs and method for the manufacture thereof |
| US5137872A (en) | 1989-09-18 | 1992-08-11 | Pitman-Moore, Inc. | Growth hormone-releasing factor analogs |
| NZ238748A (en) | 1990-06-29 | 1993-09-27 | Hoffmann La Roche | Growth hormone releasing factor (grf) analogues |
| US5847006A (en) | 1991-02-08 | 1998-12-08 | Cambridge Neuroscience, Inc. | Therapeutic guanidines |
| CA2084061A1 (en) | 1991-04-09 | 1992-10-10 | Arthur M. Felix | Growth hormone releasing factor analogs |
| CA2158782C (en) | 1994-09-23 | 2010-01-12 | Pierrette Gaudreau | Marker for growth hormone-releasing factor receptors |
| US5792747A (en) | 1995-01-24 | 1998-08-11 | The Administrators Of The Tulane Educational Fund | Highly potent agonists of growth hormone releasing hormone |
| CA2218173A1 (en) | 1995-04-14 | 1996-10-17 | The Administrators Of The Tulane Educational Fund | Analogs of growth hormone-releasing factor |
| DK0828758T3 (da) | 1995-05-26 | 2002-01-07 | Theratechnologies Inc | Kimæriske fedtlegeme-pro-GRF-analoger med forøget biologisk potensering |
| EP0922446A1 (en) | 1997-12-03 | 1999-06-16 | Applied Research Systems Ars Holding N.V. | Solution-phase site-specific preparation of GRF-PEG conjugates |
| US6696063B1 (en) | 1998-12-30 | 2004-02-24 | Applied Research Systems Ars Holding N.V. | Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy |
| KR20020047096A (ko) | 1999-07-26 | 2002-06-21 | 크로커 사무엘 에스 | 초활성 돼지 성장 호르몬 분비 호르몬 유사체 |
| US7256258B2 (en) | 2000-10-05 | 2007-08-14 | Ares Trading S.A. | Regioselective liquid phase pegylation |
| EP1539959A2 (en) | 2002-09-18 | 2005-06-15 | Centre Hospitalier de l'Université de Montréal (CHUM) | Ghrh analogues |
| WO2004067548A2 (en) | 2003-01-31 | 2004-08-12 | Theratechnologies Inc. | Chemically modified metabolites of regulatory peptides and methods of producing and using same |
| AU2003229222B2 (en) | 2003-05-29 | 2009-11-12 | Theratechnologies Inc. | GRF analog compositions and their use |
| US8293708B2 (en) * | 2005-08-30 | 2012-10-23 | Novo Nordisk Health Care A/G | Liquid formulations N-terminal serine of pegylated growth hormone |
| EP1834962A1 (de) | 2006-03-15 | 2007-09-19 | Biotecon Therapeutics GmbH | PEGyliertes mutiertes Clostridium botulinum Toxin |
| US20110021429A1 (en) | 2007-10-01 | 2011-01-27 | Pierrette Gaudreau | Renoprotection by growth hormone-releasing hormone and agonists |
| US20110065633A1 (en) | 2008-01-30 | 2011-03-17 | Indiana University Research And Technology Corporation | Ester-based peptide prodrugs |
| US8796216B2 (en) | 2008-06-12 | 2014-08-05 | Syntaxin Limited | Suppression of neuroendocrine diseases |
| BRPI0915142A8 (pt) | 2008-06-12 | 2018-01-02 | Syntaxin Ltd | Polipeptídeos, ácido nucleico e usos dos mesmos |
| US20110288011A1 (en) | 2008-12-05 | 2011-11-24 | Jean-Paul Castaigne | Peptide therapeutic conjugates and uses thereof |
| BR112013027150A2 (pt) * | 2011-04-21 | 2017-06-06 | Theratechnologies Inc | thera |
| TW201806968A (zh) | 2011-10-18 | 2018-03-01 | 艾利倫治療公司 | 擬肽巨環化合物 |
| US9079974B2 (en) | 2011-12-21 | 2015-07-14 | The University Of Miami | GH-RH analogs with potent agonistic effects |
| CN104946659A (zh) * | 2015-03-27 | 2015-09-30 | 杭州北斗生物技术有限公司 | 重组人生长激素的制备方法及其peg化修饰物的制备方法 |
| US20170037105A1 (en) * | 2015-08-03 | 2017-02-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
-
2017
- 2017-04-18 MX MX2018012716A patent/MX2018012716A/es unknown
- 2017-04-18 ES ES17785199T patent/ES2824781T3/es active Active
- 2017-04-18 HU HUE17785199A patent/HUE052802T2/hu unknown
- 2017-04-18 CN CN201780021914.8A patent/CN109153712B/zh not_active Expired - Fee Related
- 2017-04-18 WO PCT/CA2017/050475 patent/WO2017181277A1/en not_active Ceased
- 2017-04-18 AU AU2017254754A patent/AU2017254754B2/en not_active Ceased
- 2017-04-18 PL PL17785199.5T patent/PL3445778T3/pl unknown
- 2017-04-18 SG SG11201808880PA patent/SG11201808880PA/en unknown
- 2017-04-18 EP EP17785199.5A patent/EP3445778B1/en active Active
- 2017-04-18 US US16/094,565 patent/US10918730B2/en active Active
- 2017-04-18 US US15/490,618 patent/US9988428B2/en not_active Expired - Fee Related
- 2017-04-18 DK DK17785199.5T patent/DK3445778T3/da active
- 2017-04-18 PT PT177851995T patent/PT3445778T/pt unknown
- 2017-04-18 RU RU2018140501A patent/RU2748576C2/ru active
- 2017-04-18 JP JP2018555634A patent/JP7134093B2/ja not_active Expired - Fee Related
- 2017-04-18 CA CA3021231A patent/CA3021231A1/en active Pending
- 2017-04-18 BR BR112018070929-8A patent/BR112018070929A2/pt not_active IP Right Cessation
- 2017-04-18 KR KR1020187033365A patent/KR102520348B1/ko active Active
-
2018
- 2018-10-14 IL IL262356A patent/IL262356B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3445778A4 (en) | 2019-05-01 |
| US20170296628A1 (en) | 2017-10-19 |
| PL3445778T3 (pl) | 2021-02-22 |
| RU2018140501A (ru) | 2020-05-19 |
| US10918730B2 (en) | 2021-02-16 |
| RU2748576C2 (ru) | 2021-05-27 |
| AU2017254754B2 (en) | 2021-02-04 |
| IL262356A (en) | 2018-11-29 |
| US20190209699A1 (en) | 2019-07-11 |
| KR102520348B1 (ko) | 2023-04-10 |
| US9988428B2 (en) | 2018-06-05 |
| EP3445778B1 (en) | 2020-07-15 |
| ES2824781T3 (es) | 2021-05-13 |
| PT3445778T (pt) | 2020-10-15 |
| DK3445778T3 (da) | 2020-10-12 |
| EP3445778A1 (en) | 2019-02-27 |
| BR112018070929A2 (pt) | 2019-02-26 |
| JP7134093B2 (ja) | 2022-09-09 |
| IL262356B2 (en) | 2023-06-01 |
| CA3021231A1 (en) | 2017-10-26 |
| JP2019516675A (ja) | 2019-06-20 |
| CN109153712B (zh) | 2022-09-16 |
| SG11201808880PA (en) | 2018-11-29 |
| WO2017181277A1 (en) | 2017-10-26 |
| KR20180135016A (ko) | 2018-12-19 |
| HUE052802T2 (hu) | 2021-05-28 |
| CN109153712A (zh) | 2019-01-04 |
| AU2017254754A1 (en) | 2018-11-01 |
| MX2018012716A (es) | 2019-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018068177A2 (cg-RX-API-DMAC10.html) | ||
| BR112019002665A2 (cg-RX-API-DMAC10.html) | ||
| BR112019001429A2 (cg-RX-API-DMAC10.html) | ||
| BR112019008318A2 (cg-RX-API-DMAC10.html) | ||
| BR212018070320U2 (cg-RX-API-DMAC10.html) | ||
| BR112019011044B1 (pt) | Compostos de pirazol substituído, seu uso, e composição farmacêutica | |
| BR112019008988B1 (pt) | Método realizado por um primeiro equipamento de usuário, primeiro equipamento de usuário, método realizado por uma estação base, e, estação base | |
| BR112019008501B1 (pt) | Método realizado por um equipamento de usuário, método realizado por um nó de rede, equipamento de usuário, nó de rede, e, meios de armazenamento legíveis por computador | |
| BR112019003116B1 (pt) | Configuração de símbolo de rajada comum de uplink | |
| BR112018075550B1 (pt) | Método para reparo de arquivo de intervalo de bytes, dispositivo de computação e memória | |
| BR112018076493B1 (pt) | Sistemas e métodos para detecção de posição de feixe de luz | |
| BR112018073794B1 (pt) | Partícula, método de geração da partícula, vacina ou composição farmacêutica | |
| BR112018073322B1 (pt) | Método para comunicação sem fio realizado por um equipamento de usuário (ue), método para comunicação sem fio realizado por uma estação base (bs), aparelho para comunicações sem fio, e, memória legível por computador | |
| BR122026002520A2 (pt) | Célula, conjunto de vetores para expressar uma proteína de ligação a antígeno biespecífica em uma célula, conjunto de vetores, sistema, método, e, método para produção de uma proteína de ligação a antígeno | |
| BR112019006736A2 (cg-RX-API-DMAC10.html) | ||
| CN303646022S (zh) | 包装盒（逆变器500w） | |
| CN303642044S (zh) | 大跨径桥梁塔顶（徽派元素） | |
| CN303579380S (zh) | 发动机 | |
| CN303538712S (zh) | 汽车杯（sp-2038） | |
| CN303606394S (zh) | 便携式发球机 | |
| CN303568995S (zh) | 电动牙刷刷头 | |
| CN303536045S (zh) | 嫁衣（15） | |
| CN303536551S (zh) | 背提包（wb08018） | |
| CN303535547S (zh) | 冰棒(北冰熊掌脆皮雪糕冰棒) | |
| CN303535546S (zh) | 冰棒(北极兔雪糕冰棒) |